NUE
58
-3
FDX
55
2
USB
64
2
NOV
50
-2
GE
71
3
MRK
46
-4
PPL
64
4
AN
61
-2
NTRS
74
-3
VMC
59
2
PNW
66
2
ADP
70
2
LH
55
3
FTI
79
15
PWR
71
3
CRM
59
5
AON
65
2
FOXA
66
3
AVGO
45
3
AFL
53
4
NUE
58
-3
FDX
55
2
USB
64
2
NOV
50
-2
GE
71
3
MRK
46
-4
PPL
64
4
AN
61
-2
NTRS
74
-3
VMC
59
2
PNW
66
2
ADP
70
2
LH
55
3
FTI
79
15
PWR
71
3
CRM
59
5
AON
65
2
FOXA
66
3
AVGO
45
3
AFL
53
4
Financhill
Back

Kymera Therapeutics Stock Predictions

Your Summer Trading Shortcut

Try it free today.
Buy
70

KYMR
Kymera Therapeutics

Last Price:
$44.81
Seasonality Move:
5.78%

7 Day Trial

ALL ACCESS PASS

$ 7

Slow Market? Try This Instead

See how it works now.

Kymera Therapeutics Stock Forecast

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 6.2% based on the past 4 years of stock performance.
  • Kymera Therapeutics has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Kymera Therapeutics Stock Undervalued?
    The current Kymera Therapeutics [KYMR] share price is $44.79. The Score for KYMR is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Kymera Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 6.2% based on the past 4 years of stock performance.

Kymera Therapeutics Stock Rating

Buy
70
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics overpriced?

  • Kymera Therapeutics has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Kymera Therapeutics Stock Price History

Is KYMR stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com

52-Week Data

52-Week High:
53.27
52-Week Low:
19.45

Prediction Charts

Market Cap:
2.9B
Price in USD:
44.79
Volume:
240.5K
Beta:
2.16

Technical Analysis

SMA50:
38.00
SMA100:
34.50
SMA200:
39.54
52-Wk Change:
48.51%

Stock Predictions

  • Is Kymera Therapeutics stock public?
    Yes, Kymera Therapeutics is a publicly traded company.
  • What is the Kymera Therapeutics stock quote today?
    The Kymera Therapeutics stock price is 44.79 USD today.
  • How to buy Kymera Therapeutics stock online?
    You can buy Kymera Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-13 46.22 46.96 47.33 46.04
Jun-16 47.05 46.84 47.75 45.72
Jun-17 46.45 46.35 46.97 45.72
Jun-18 46.13 46.44 47.51 45.73
Jun-20 46.51 45.87 46.66 44.51
Jun-23 45.74 46.29 46.80 45.01
Jun-24 47.30 47.14 47.73 45.89
Jun-25 45.56 46.47 46.82 44.62
Jun-26 45.51 45.71 46.21 44.00
Jun-27 46.43 44.12 46.67 43.51
Jun-30 44.66 43.64 45.03 43.58
Jul-1 45.02 44.44 45.45 43.84
Jul-2 44.70 44.53 45.46 44.08
Jul-3 45.04 44.79 45.15 44.26

Kymera Therapeutics Earnings

Kymera Therapeutics Earnings Report: Per Share Kymera Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Kymera Therapeutics Forecast Revenue Growth

Kymera Therapeutics Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.17 per share, a decrease this year of $0.67 per share, and a decrease next year of $0.49 per share.

* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.